Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06234280
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:59.634321+00:00
Published At
2024-01-31T00:00:00+00:00
Record Updated At
2024-01-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Symptomatic Peripheral Artery Disease With Femoropopliteal Lesions", "Moderate or Severe Claudication (Rutherford Category 2 or 3)", "Critical Limb Ischemia (Rutherford Category 4 or 5)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-01-31"
protocolSection.identificationModule.nctId
"NCT06234280"
protocolSection.identificationModule.officialTitle
"Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Symptomatic Peripheral Artery Disease With Femoropopliteal Lesions (protocolSection.conditionsModule.conditions)
  • Moderate or Severe Claudication (Rutherford Category 2 or 3) (protocolSection.conditionsModule.conditions)
  • Critical Limb Ischemia (Rutherford Category 4 or 5) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.